DOSIST Journal

Insights driving
precision medicine

Cutting-edge insights on peptide therapy, metabolic health, and regenerative medicine — written and reviewed by our clinical team for practitioners and patients alike.

See the science
001
Science

What is GLP-1 and How Does It Work?

Glucagon-like peptide-1 receptor agonists are transforming metabolic medicine. Here's what you need to know about the science behind GLP-1 therapy.

6 min read · 15 Mar 2026
002
Clinical

Semaglutide vs Tirzepatide: A Clinical Comparison

Two leading GLP-1 therapies compared head-to-head. We break down efficacy, side effects, and which may be right for you.

7 min read · 10 Mar 2026
003
Science

BPC-157: The Body's Natural Repair Peptide

Body Protection Compound-157 is one of the most studied regenerative peptides. Learn how it supports tissue repair, gut healing, and recovery.

6 min read · 05 Mar 2026
004
Wellness

NAD+ and Cellular Energy: What the Science Says

Nicotinamide adenine dinucleotide is essential for cellular metabolism. We examine the evidence behind NAD+ supplementation and longevity.

7 min read · 28 Feb 2026
005
Clinical

Understanding Peptide Therapy Side Effects

Every effective treatment has a risk-benefit profile. Here's an honest, evidence-based overview of common peptide therapy side effects.

6 min read · 20 Feb 2026
006
Wellness

The Future of Compounded Medicine in South Africa

Compounding pharmacies are redefining personalised medicine in South Africa. We explore the regulatory landscape and what it means for patients.

7 min read · 12 Feb 2026